# Cathay Biotech

> Cathay Biotech is a VC fund in Shanghai backing Medical and Life Science. See 1 investment, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 1
- Last investment: Feb 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/cathay-industrial-biotech/
- Website: http://www.cathaybiotech.com/en/

Cathay Biotech is a global technology leader in synthetic biology and the use of bio-processes to produce new materials on an industrial scale. Cathay’s long chain diacids are a perfect example demonstrating the potential for renewable bio-manufacturing to commercially displace traditional chemical processes. Cathay also developed and became thefirst commercial producer of pentanediamine from renewable materials. Having the two key monomers to produce polyamides, Cathay also is a global innovator in the commercialization of new and unique renewable polyamides for the engineering polymer and textile markets. As a game-changing production technology, bio-production starts with biomass and other raw materials for biological conversion to higher value products. The nature of bio-production requires environmentally friendly and mild conditions that are inherently economical. The goal of Cathay’s synthetic biology development programs is to address the excessive dependence of humans on traditionally produced chemicals as well as the subsequent environmental damage and worker safety issues associated with their production. Cathay’s headquarters and R&D are located within Zhangjiang Hi-Tech park in Shanghai, P.R. China and the two production sites are in Jinxiang, Shandong Province, and Wusu, Xinjiang Province, also in China.

## Contacts

5 contacts available for Cathay Biotech. Shizune tracks 7 team members at Cathay Biotech. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cathay-industrial-biotech?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dr. Xiucai Liu | Founder, Chairman and Chief Executive Officer | 0 | https://shizune.co/investors/profile/xiucai-liu |
| Joachim Rudolf | Chief Financial Officer | 0 | https://shizune.co/investors/profile/joachim-rudolf |
| Alexander Kedo | VP | 0 | https://shizune.co/investors/profile/alexander-kedo |
| Benliang Hou | VP | 0 | https://shizune.co/investors/profile/benliang-hou |
| Hongguang Zhang | VP | 0 | https://shizune.co/investors/profile/hongguang-zhang |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MoleculeMind | MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform. | $14.6M | Seed | Feb 20, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Lenovo Capital and Incubator Group (LCIG)](https://shizune.co/investors/profile/lenovo-capital-and-incubator-group-lcig) — VC Fund, 2 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)

## FAQ

### What does Cathay Biotech invest in?

Cathay Biotech invests primarily in Medical, Life Science and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cathay Biotech?

Public channels for Cathay Biotech include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cathay Biotech?

The team at Cathay Biotech includes Dr. Xiucai Liu (Founder, Chairman and Chief Executive Officer), Joachim Rudolf (Chief Financial Officer) and Alexander Kedo (VP), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co